Other trends demonstrating a possible mechanism for CS/IL-12 activity after CA included increased early levels of Klrk1 (NKG2D) in the dLN (Figure S6A), and higher levels of Itgam (CD11b) in the tumor on day 3 (Figure S6J). Here, KLRK1 is linked to neoplasm.